“You don't think they know already ????” T
Post# of 148294
The FDA has not seen the data from the S/C trial. NP made that clear in the PR this morning, “We are very thankful the FDA is allowing severe-to-critical COVID-19 patients access to Vyrologix™ (leronlimab) again under eIND WHILE WE AWAIT THE UNBLINDING OF DATA from our recently completed Phase 3 registrational trial.“ The EINDs will be approved until a EUA is given or until the data shows lack of efficacy (which seems unlikely). Investors who continue to sell the idea that the FDA is actively reviewing the have been wrong time and time again.